Alina Hartmann

Alina Hartmann is a seasoned finance professional with extensive experience in clinical trial budget management and strategic business partnerships. Currently serving as Associate Director at Genmab since November 2022, Alina oversees a clinical trials budget of 12 DKK billion and leads the development of a Clinical Trial Budget Dashboard using PowerBI. Prior roles include Senior Manager at Novo Nordisk, with responsibilities such as managing a 4 DKK billion budget for rare diseases and overseeing a 37 DKK billion clinical cost budget process. Alina's background includes significant positions at EY, DFDS, Saxo Bank, and Vivaldi LTD, showcasing expertise in financial analysis, strategic advisory, and project management. Alina holds a Master of Science in Finance and International Business from Aarhus University and several ACI certifications.